Abstract
The discovery of prion proteins and the diseases which are associated with them still present scientists and clinicians with a number of problems. There are clearly risks with the use of living cells and materials of animal origin to produce therapeutic compounds with respect to the transmission of prion protein. However the medical benefit many of these compounds has to be weighed against this. It is clear a number of groups are continuing to unravel the highly complex relationships of prion biology and pathology and it is only when this is clearly established that the community can decide on these issues. Until this time the scientific community must rely on the best research available and provide guidance from this.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baron H, Safar J, Groth D, DeArmond SJ and Prusiner SB (1999) 'Biosafety Issues in Prion Diseases', in SB Prusiner (ed.) Prion Biology and Disease, Cold Spring Harbour University Press.
Borchelt DR, Scott M, Taraboulos A, Stahl N and Preusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J C B 110: 743-752.
Brown P, Gibbs CJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG and Gajdusek DC (1994) Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513-529.
Brown P (1995) Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin in Haematol 2: 472-477.
Brown P (1996) 'Environmental Causes of Human Spongiform Encephalopathy', in HF Baker and RM Ridley (eds), Prion Diseases (pp. 139-154), Humana Press, Totowa, United States.
Butler DA, Scott MRD, Bockman JM, Borchelt DR, Taraboulos A, Hsiao KK, Kingsbury DT and Prusiner SB (1988) Scrapie infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol 62: 1558-1564.
Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety
Medicines (1992) EEC Regulatory Document. Note for guidance. Guidelines for minimizing the risk of transmitting agents causing spongiform encephalopathy via medicinal products. Biologicals 20: 155-158.
Cuille J and Chelle PL (1939) Experimental transmission of trembling to the goat. C. R. Seances Acad Sci 208: 1058-1060.
Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B and Cowan D (1974) Possible person to person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290: 692-693.
Gadjusek DC (1988) Transmissible and non-transmissible amyloidoses: Autocatalytic post-translational conversion of host precursor proteins to beta pleated confirmations. J Neuroimmunol 20: 95-110.
Gabriel JM, Oesch B, Kretzschmar H, Scott M and Prusiner SB (1992) Molecular cloning of candidate chicken prion protein. Proc Natl Acad Sci USA 89: 9097-9101.
Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen FE and Presiner SB (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propigation. Proc Natl Acad Sci USA 94: 10069-10074.
Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM and Diringer H (1987) Mouse polyclonal and monoclonal antibody to scrapie associated fibril proteins. J Virol 61: 3688-3693.
Kasper KC, Bowman KA, Stites DP and Prusiner SB (1981) 'Toward Development of Assays for Scrapie Specific Antibodies', in JW Steilen (ed.) Hamster Immune Responses in Infectious and Oncologic Diseases (pp. 401-413).
Kretzschmar HA, Prusiner SB, Stowring LE and DeArmond SJ (1986) Scrapie prion proteins are synthesised in neurons. Am J Pathol 122: 1-5.
Lasmezas CI, Deslys JP, Demalmay R, Adjou KT, Lamoury F, Dormont D, Robain O, Ironside JW and Hauw JJ (1996) BSE transmission to macaques. Nature 381: 743-744.
Manuelidis EE, De Figueiredo JM, Kim JH, Fritch WW and Manuelidis L (1988) Transmission to animals of CJD from human bloot. Lancet 2: 896-897.
Pattison IH and Millson GC (1961) Further experimental observations on Scrapie. J Comp Pathol 71: 350-359.
Saborio GP, Permanne B and Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplificatiuon of protein misfolding. Nature 14: 810-813.
Schatzl HM, Da Costa M, Taylor L, Cohen FE and Prusiner SB (1995) Prion protein gene variation among primates. J Mol Biol 245: 10962-10966.
Schatzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC and Prusiner SB (1997) A hypothalamic neuronal cell line persistently infected with Scrapie prions exhibits apoptosis. J Virol 71: 8821-8831.
Tateishi J, Kitamoto T, Hoque MZ and Furukawa H (1999) Experimental transmission of Creutzfelt-Jakob disease and related diseases in rodents. Neurology 46: 532-537.
Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M and Bradley R (1987) A novel progressive spongiform encephalopathy in cattle. Vet Rec 121, 419-420.
Wilesmith JW, Ryan JB and Atkinson MJ (1991) Bovine spongiform encephalopathy: Epidemiological studies on its origin. Vet Rec 123: 638-644.
Will RG, Alpers MP, Dormont D, Schonberger LB and Tateishi J (1999) 'Infectious and Sporadic Prion Disease', in SB Prusiner (ed.) Prion Biology and Disease, Cold Spring Harbour University Press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Galbraith, D.N. Transmissible spongiform encephalopathies and tissue cell culture. Cytotechnology 39, 117–124 (2002). https://doi.org/10.1023/A:1022935117274
Issue Date:
DOI: https://doi.org/10.1023/A:1022935117274